[1]
“Toxicity and anti-tumour activity of organotin (IV) compounds”, Baghdad J. Biochem. Appl. Biol. Sci., vol. 3, no. 02, pp. 99–108, Jun. 2022, doi: 10.47419/bjbabs.v3i02.131.